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Results: Dose-volume-histogram data for the standard (solid) 
and escalated (dashed) arms for one patient is presented 
(Figure 1). Centres entering the NARLAL2 trial must 
successfully pass a workshop evaluation on delineation, PET 
determination, treatment planning, and IGRT strategy. 
Additionally, all participating centres should expect to enrol 
≥5 patients/year, use 4D-CT and PET, inverse treatment 
planning, daily online match on soft tissue, and have an 
adaptive treatment strategy. Planning and treatment of the 
initial two patients within each centre are thoroughly 
investigated by a small QA work group consisting of 2 clinical 
oncologists and 4 physicists. Furthermore, every six month 
each centre will be visited by an external oncologist in order 
to ensure that guidelines are still followed throughout the 
duration of the trial. 
 
 
Conclusion: The NARLAL2 trial started patient accrual in 
January 2015 based on this extensive QA work. 
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Purpose or Objective: The purpose of the study was to 
compare a lithium formate dosimetry system with a lithium 
fluoride TL dosimetry system as used in a solid phantom 
developed for remote end-to-end audits of advanced 
radiotherapy treatments, such as IMRT and VMAT. This type 
of inter-dosimeter comparison is of benefit for better 
understanding of advantages and limitations in the use of 
these dosimeters in remote audit programs for radiotherapy.  
 
Material and Methods: A phantom was designed by a 
multinational coordinated research group (Coordinated 
Research Project E24018) with the intention to be used for 
remote end-to-end audits of advanced radiotherapy 
treatment (IMRT and VMAT). The phantom is made of 
polystyrene and includes solid water volumes representing a 
target region (PTV) and an organ at risk (OAR) with two 
measurement points in each. For an audit, the phantom is to 
be loaded with either TLD or EPR dosimeters and sent to 
external clinics to be treated using their local procedure for 
IMRT or VMAT. Dimensions of the active volume of the 
dosimeters used were: 20 mm length and 3 mm diameter for 
TLD, 5 mm height and 4.5 mm diameter for the EPR 
dosimeter. In addition, gafchromic film is used in the audit 
but this is not a subject of the current study. Irradiations 
were performed using VMAT technique and the doses 
determined by the TLDs and EPR dosimeters were compared 
with the TPS calculated doses.  
Results: The absorbed dose determined by the EPR and TL 
dosimeters agreed within 2% with the TPS calculated doses in 
the PTV. In the OAR the discrepancy was larger; the dose 
determined by the EPR system was 3% lower compared to the 
TPS dose while the dose determined by the TLD was 5% 
higher than the TPS dose. The dose difference in the OAR was 
expected to be larger due to the steep dose gradients in this 
region over the dosimeter volume and the phantom 
positioning uncertainties involved.  
 
Conclusion: Both dosimetry systems agree with the TPS 
calculated doses within 2% in the PTV and 5% in the OAR. This 
study shows that both dosimetry systems give results 
acceptable for this application and can be used for remote 
dosimetry audits of IMRT or VMAT. The EPR dosimeters have 
higher resolution due to their smaller size. This is an 
advantage of the EPRs over the TLDs since it is possible to 
resolve dose gradients to a higher extent.  
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Purpose or Objective: Radiotherapy is one of the primary 
treatment options in cancer management. Radiotherapy is 
recognised as one of the safest areas of modern medicine; 
however, when errors occur, the consequences for the 
patient can be significant.  
The rapid development of new technology has significantly 
changed the way in which radiotherapy is planned and 
delivered. Quality and safety programs in radiotherapy have 
been recommended by international bodies, such ESTRO and 
AAPM.  
The purpose of this work is twofold: to report on the long-
term use of an event reporting and learning system in an RT 
department to record and classify events, and to compare a 
restricted access system to an open-access system 
 
Material and Methods: A voluntary web-based safety 
information database for RT was designed for reporting 
individual events in RT and was clinically implemented in 
2011. An event was defined as any occurrence that could 
have, or had, resulted in a deviation in the intended delivery 
of cancer care. The aim of the reporting systemm was to 
encourage process improvement in patient care and safety.  
During the RT process, when something goes wrong and 
results in event, it is initially recorded and reported within 
the RT Department. Initially only the management group 
registered events. From June 2012 all team at RT Department 
(radiation oncologist, radiation therapists, medical physicists, 
nurses, technicians, dosimetrists, medical secretary) can 
directly register events. All events were analyzed inside a 
management group who selected and proposed actions to be 
taken. 
 
Results: We analyzed events from 2011 to 2014 for 6108 
patients who have undergone radiation treatment at our 
hospital. Over this period of time 298 events were reported. 
After the event reporting system became open access (June 
2012), the registered number of events increased significally: 
from 22 in 2011 to 44 in 2012, 120 in 2013 and 112 in 2014. 
The spectrum of reported deviations extendent from minor 
workflow issues to errors in treatment delivery. 
The distribution of the professional who registered the event 
was: 
 
 
 
